Monday, January 29, 2007

Amgen: Bad News Regarding its Anemia Drug

The drug is known as Aranesp. According to recent news from a drug trial, there is an increased risk of death in cancer patients who are not on chemotherapy when taking it.

Aranesp is already approved for use in cancer patients who suffer anemia as a result of their chemotherapy. Amgen wanted to extend this indication to include patients who have anemia from the cancer itself.

Aranesp was already being used off-label for these non-chemotherapy cancer patients. Source here. Another report noted that certain patients in the trial already had "an especially dire prognosis." Source here.